Blood Biomarkers for Neurodegeneration

Clinical MedicineUpdated Aug 18, 2026Version v1

Evidence

Public papers linked to this topic and used as evidence for gaps, timelines, and knowledge views.

16 papers

Showing 1-12 of total 16 evidence records.

Open a paper to inspect abstract, source links, and topic context.

2025CrossrefDirectly related30 citations

2024OpenAlexDirectly related824 citations

Diagnostic Accuracy of a Plasma Phosphorylated Tau 217 Immunoassay for Alzheimer Disease Pathology

Nicholas J. Ashton; Wagner S. Brum; Guglielmo Di Molfetta; Andréa Lessa Benedet; Burak Arslan; Erin M. Jonaitis; Rebecca E. Langhough; Karly Alex Cody; Rachael E. Wilson; Cynthia M. Carlsson; Eugeen Vanmechelen; Laia Montoliu‐Gaya; Juan Lantero‐Rodriguez; Nesrine Rahmouni; Cécile Tissot; Jenna Stevenson; Stijn Servaes; Joseph Therriault; Tharick A. Pascoal; Alberto Lleó; Daniel Alcolea; Juan Fortea; Pedro Rosa‐Neto; Sterling C. Johnson; Andreas Jeromin; Kaj Blennow; Henrik Zetterberg

Jan 22, 2024JAMA Neurology

2023OpenAlexDirectly related23 citations

Blood biomarkers and neurodegeneration in individuals exposed to repetitive head impacts

Charles Bernick; Guogen Shan; Aaron Ritter; Nicholas J. Ashton; Kaj Blennow; Juan Lantero‐Rodriguez; Anniina Snellman; Henrik Zetterberg

Oct 12, 2023Alzheimer s Research & Therapy

2022OpenAlexDirectly related246 citations

Brain-derived tau: a novel blood-based biomarker for Alzheimer’s disease-type neurodegeneration

Fernando González‐Ortiz; Michael Turton; Przemysław R. Kac; Denis S. Smirnov; Enrico Premi; Roberta Ghidoni; Luisa Benussi; Valentina Cantoni; Claudia Saraceno; Jasmine Rivolta; Nicholas J. Ashton; Barbara Borroni; Douglas Galasko; Peter Harrison; Henrik Zetterberg; Kaj Blennow; Thomas K. Karikari

Dec 27, 2022Brain

2022OpenAlexDirectly related606 citations

The Alzheimer's Association appropriate use recommendations for blood biomarkers in Alzheimer's disease

Oskar Hansson; Rebecca M. Edelmayer; Adam L. Boxer; María C. Carrillo; Michelle M. Mielke; Gil D. Rabinovici; Stephen Salloway; Reisa A. Sperling; Henrik Zetterberg; Charlotte E. Teunissen

Jul 31, 2022Alzheimer s & Dementia

2021CrossrefDirectly related192 citations

Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics

Henrik Zetterberg; Kaj Blennow

Dec 1, 2021Molecular Neurodegeneration

2021CrossrefSupporting evidence267 citations

Mammalian/mechanistic target of rapamycin (mTOR) complexes in neurodegeneration

Henry Querfurth; Han-Kyu Lee

Jul 2, 2021Molecular Neurodegeneration

2020OpenAlexDirectly related102 citations

Comparison of ELISA- and SIMOA-based quantification of plasma Aβ ratios for early detection of cerebral amyloidosis

Steffi De Meyer; Jolien Schaeverbeke; Inge M.W. Verberk; Benjamin Gille; Maxim De Schaepdryver; Emma S. Luckett; Silvy Gabel; Rose Bruffaerts; Kimberley Mauroo; Elisabeth H. Thijssen; Erik Stoops; Hugo Vanderstichele; Charlotte E. Teunissen; Rik Vandenberghe; Koen Poesen

Dec 1, 2020Alzheimer s Research & Therapy

2020OpenAlexDirectly related87 citations

Association of Cigarette Smoking With Cerebrospinal Fluid Biomarkers of Neurodegeneration, Neuroinflammation, and Oxidation

Yanlong Liu; Hui Li; Jian Wang; Qing Xue; Xiaoyu Yang; Yimin Kang; Mengjie Li; Jinzhong Xu; Guohua Li; Cunbao Li; Hui‐Chih Chang; Kuan‐Pin Su; Fan Wang

Oct 2, 2020JAMA Network Open

2019OpenAlexDirectly related128 citations

Cerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial activation across the clinical Alzheimer's disease spectrum

Isabelle Bos; Stephanie J. B. Vos; Frans Verhey; Philip Scheltens; Charlotte E. Teunissen; Sebastiaan Engelborghs; Kristel Sleegers; Giovanni B. Frisoni; Olivier Blin; Jill Richardson; Régis Bordet; Magda Tsolaki; Julius Popp; Gwendoline Peyratout; Pablo Martínez‐Lage; Mikel Tainta; Alberto Lleó; Peter Johannsen; Yvonne Freund‐Levi; Lutz Frölich; Rik Vandenberghe; Sarah Westwood; Valerija Dobričić; Frederik Barkhof; Cristina Legido‐Quigley; Lars Bertram; Simon Lovestone; Johannes Streffer; Ulf Andréasson; Kaj Blennow; Henrik Zetterberg; Pieter Jelle Visser

Mar 7, 2019Alzheimer s & Dementia

2018OpenAlexDirectly related11K citations

NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease

Clifford R. Jack; David A. Bennett; Kaj Blennow; María C. Carrillo; Billy Dunn; Samantha Budd Haeberlein; David M. Holtzman; William J. Jagust; Frank Jessen; Jason Karlawish; Enchi Liu; José Luís Molinuevo; Thomas J. Montine; Creighton H. Phelps; Katherine P. Rankin; Christopher C. Rowe; Philip Scheltens; Eric Siemers; Heather M. Snyder; Reisa A. Sperling; Contributors; Cerise Elliott; Eliezer Masliah; Laurie Ryan; Nina Silverberg

Apr 1, 2018Alzheimer s & Dementia

2017OpenAlexDirectly related365 citations

Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington's disease: a retrospective cohort analysis

Lauren M. Byrne; Filipe B. Rodrigues; Kaj Blennow; Alexandra Dürr; Blair R. Leavitt; Raymund A.C. Roos; Rachael I. Scahill; Sarah J. Tabrizi; Henrik Zetterberg; Douglas R. Langbehn; Edward J. Wild

Jun 8, 2017The Lancet Neurology